Does HRT Cause Weight Gain? What Estradiol, Progesterone and a GLP-1 Actually Do

Does HRT make you gain weight?

No, not on average. In randomized trials, women on menopausal hormone therapy gained no more weight than women on placebo, and HRT may slow the shift of fat toward the belly¹³. The weight that arrives in your late forties comes mostly from the menopause transition itself. Taking a GLP-1 too? Hormone therapy does not appear to blunt it.

That answer surprises a lot of women, because the fear is so common. The authors of the Cochrane review on this question opened by saying many women decline estrogen because they expect to gain weight, and miss out on its benefits as a result¹. So it helps to separate three things that tend to get blurred together: what the hormones do, what the transition does, and what you feel in the first weeks of a new prescription.

What do the trials actually show?

The most direct answer comes from a Cochrane review that pooled 22 randomized, controlled trials of hormone therapy in peri- and postmenopausal women¹. Women on estrogen alone gained an average of 0.66 kg more than women on no hormones, a difference small enough to be chance (the confidence interval ran from a 0.62 kg loss to a 1.93 kg gain). Women on estrogen plus a progestogen came out 0.47 kg lighter than non-users, again not a real difference. The reviewers' conclusion was plain: these regimens "do not cause extra weight gain in addition to that normally gained at menopause."

Larger trials point the same way on body shape. In a substudy of the Women's Health Initiative, 835 women were randomly assigned to estrogen plus progestin or a placebo and scanned by DEXA for three years². The hormone group lost almost no lean tissue (0.04 kg) while the placebo group lost 0.44 kg, and the hormone group's fat sat less on the trunk relative to the legs. The authors called the effects small, which is the honest framing. Still, the direction is the opposite of what most women fear.

A meta-analysis of 107 trials found that hormone therapy reduced abdominal fat by about 6.8% in women without diabetes and lowered insulin resistance and new cases of diabetes³. That does not make HRT a weight-loss drug. A 2026 clinical review for obesity specialists puts it well: hormone therapy may soften central fat gain and help preserve body composition, but it "is not indicated as a primary weight loss intervention"⁶.

Does estradiol cause weight gain?

Estradiol is the main estrogen in most modern hormone therapy, sold as a pill, a skin patch, a gel or a spray for whole-body (systemic) use, and as a vaginal cream, tablet or ring for local symptoms⁸. The trial data above covers estrogen broadly, and none of it shows estradiol adding fat.

What some women do notice in the first weeks is fluid. ACOG lists bloating from fluid retention and temporary breast soreness among the common side effects of hormone therapy, alongside spotting and headaches⁸. That can show up as a pound or two on the scale and a tighter waistband, and it tends to settle. It is water, not fat, and it is worth telling your prescriber about if it lingers, because a change of dose or route sometimes helps.

The route matters for other reasons too. ACOG notes that patches, sprays and rings may carry less clot risk than pills taken by mouth⁸, and the meta-analysis above found that oral estrogen raised C-reactive protein, an inflammation marker, while skin-applied estrogen did not³. If you are choosing between a pill and a patch, weight is not the deciding factor. Your clot risk, your other medications and what you will actually keep using are.

Does progesterone cause weight gain?

If you still have a uterus and take systemic estrogen, you also need a progestogen. Estrogen alone can thicken the uterine lining and raise the risk of uterine cancer, and the progestogen protects against that⁸. It can be a pill, part of a combined pill or patch, or a progestin-releasing IUD. Many prescribers use micronized progesterone, which is chemically the same as the hormone your ovaries make.

Progestogens get blamed for bloating, and some women do feel puffy on them, especially on cyclic regimens where the progestogen is taken 10 to 14 days a month⁸. But the Cochrane numbers for combined therapy show no added weight on average¹. If you feel worse on one progestogen, there are others; stopping it while staying on systemic estrogen is not a safe fix if you have a uterus.

Why do women gain weight at menopause anyway?

Because the transition changes body composition, even when the scale barely moves. The best data comes from SWAN, a long-running US study that scanned women by DEXA every year across menopause⁴. At the start of the transition, the rate of fat gain doubled and lean mass began to fall. Both trends continued until about two years after the final period, then leveled off. Total weight, oddly, kept climbing at the same steady pace it had before. In other words, the number on the scale did not jump, but what it was made of changed.

A four-year study that measured belly fat by CT found the same pattern from a different angle⁵. All the women gained fat under the skin as they aged, but only the women who went through menopause gained visceral fat, the deeper fat around the organs. Their sleeping energy use fell more, and their fat burning dropped by about 32%. Physical activity had already started falling two years before menopause.

That is why so many women start HRT at the same time as the weight changes begin and connect the two. The timing overlaps; the cause mostly does not. Our guide to menopause belly goes deeper into why the fat moves and what reduces it.

Can you take HRT and a GLP-1 together?

Yes. They act on different systems, and the Zepbound label does not list menopausal hormone therapy among its drug interactions¹¹. The best data we have even suggests the combination may work slightly better.

A Mayo Clinic study looked back at postmenopausal women prescribed semaglutide for weight and compared 16 women on hormone therapy with 90 who were not⁹. After 12 months, the women on hormone therapy had lost an average of 16% of their body weight, against 12% for the others, and more of them reached the 5% and 10% marks. The difference held after the researchers adjusted for other factors.

Read that carefully, though. It is a small, retrospective study, not a trial, and women who take hormone therapy may differ in other ways (access to care, health, follow-up). The authors themselves call for larger studies, and the 2026 review says the same about every combination finding so far⁶. What it does show is that HRT did not blunt semaglutide. Large trials of the drugs themselves found strong results at every life stage: in SURMOUNT-1, women lost about 23% of body weight on tirzepatide whether they were perimenopausal or postmenopausal, with waist reductions of about 20 cm¹².

One practical caution: oral hormones and tirzepatide

GLP-1 medicines slow how fast the stomach empties, which can change how oral medicines are absorbed. The Zepbound label says so directly. In the label's own study, the first 5 mg dose cut the peak level of the estrogen in a birth control pill by 59% and total exposure by about 20%, and the label tells women on oral birth control to switch to a non-oral method or add a barrier method for four weeks after starting and after each dose increase¹¹. That instruction is about contraception, not menopausal estradiol, but the same stomach-emptying effect applies to any pill, and it is largest after the first dose and each increase. If your hot flashes return or you notice spotting after a dose increase, mention it. A patch or gel skips the stomach entirely. Our guide to GLP-1s and birth control covers the contraception side in full.

What changed in the FDA's HRT warnings?

On November 10, 2025, the FDA asked companies that make menopausal hormone therapy to remove the cardiovascular disease, breast cancer and probable dementia statements from the boxed warning, the black-box warning at the top of the label¹⁰. On February 12, 2026, it approved the first six updated labels, covering systemic combined therapy, systemic estrogen alone, systemic progestogen and vaginal estrogen, and said 29 companies had submitted changes¹³.

What did not change: the risks are still described in each label's warnings section, and hormone therapy is still not for everyone. ACOG says systemic therapy is usually not recommended for women who have had breast or endometrial cancer, a stroke, a heart attack, blood clots or liver disease⁸. If breast cancer is part of your history, our guide to GLP-1 care after breast cancer is the better starting point.

The label change also lines up with what The Menopause Society has said since 2022: for women under 60 or within 10 years of menopause without contraindications, the benefits of hormone therapy for hot flashes and bone loss outweigh the risks⁷. None of this changes the weight answer. It does mean more women are revisiting HRT right now, often at the same time as they consider a GLP-1.

Which comes first, HRT or a GLP-1?

There is no rule, and the two answer different problems. Hormone therapy treats hot flashes, night sweats, vaginal symptoms and bone loss⁷. A GLP-1 treats excess weight and the metabolic risk that comes with it. Some practical ways women and their clinicians think about it:

• If hot flashes and broken sleep are the main problem, treating them first can make everything else easier. Short sleep is linked to more belly fat, as our menopause belly guide explains.
• If weight and blood sugar are the main problem, a GLP-1 does that job far better than hormones can.
• If both are real, the Mayo data suggests there is no reason to pick one. Starting them a few weeks apart makes it easier to tell which side effect belongs to which drug.
• Either way, protect muscle. The transition already costs lean mass, and fast weight loss adds to it. Our guide to muscle loss on a GLP-1 covers protein and strength training targets, and our guide to bone density on a GLP-1 covers the other half of that risk.

Where can you get HRT and a GLP-1 from one program?

Many telehealth weight programs do not prescribe hormones at all, so if you want both from one clinician, check before you sign up. A few of the programs we review do list menopause care next to their GLP-1s:

• Gala Health (a partner) sells an HRT and menopause line beside its weight-loss program. See our Gala Health review for prices and plan terms.
• Alloy says its prescribers hold The Menopause Society's certified practitioner credential, and it sells weight care next to a full hormone therapy line. See our Alloy review.
• Goldspan Health prices estradiol cream and progesterone in the same catalog as its GLP-1s. See our Goldspan Health review.

Our GLP-1 board for menopause lists more programs, and our guide to GLP-1 care through perimenopause and menopause covers what good midlife care looks like. If you would rather see someone in person, our guide to finding a menopause specialist near you explains how.

Educational content, not medical advice. Talk to a licensed clinician before starting any treatment.